DPP-4 (CD26) Inhibitor Alogliptin Inhibits Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice

DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes

(2010) Nga N. Ta et al.   ATHEROSCLEROSIS

The effect of fibrate–statin combination therapy on cardiovascular events: a retrospective cohort analysis

(2010) Anthony S. Wierzbicki et al.   CURRENT MEDICAL RESEARCH AND OPINION

Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects

(2010) M. R. Dasu et al.   DIABETES CARE

Effects of chronic administration of alogliptin on the development of diabetes and β-cell function in high fat diet/streptozotocin diabetic mice

(2010) X. Zhang et al.   DIABETES OBESITY & METABOLISM

Alogliptin

(2010) Lesley J. Scott   DRUGS

Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes

(2010) Ulrich Werner et al.   REGULATORY PEPTIDES

Emerging Drug Candidates of Dipeptidyl Peptidase IV (DPP IV) Inhibitor Class for the Treatment of Type 2 Diabetes

(2009) Rajesh Gupta et al.   CURRENT DRUG TARGETS

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

(2009) Richard E. Pratley et al.   CURRENT MEDICAL RESEARCH AND OPINION

Combination treatment with alogliptin and voglibose increases active GLP-1 circulation, prevents the development of diabetes and preserves pancreatic beta-cells in prediabeticdb/dbmice

(2009) Y. Moritoh et al.   DIABETES OBESITY & METABOLISM

Eplerenone does not attenuate diabetes-associated atherosclerosis

(2009) Philip JW Koh et al.   JOURNAL OF HYPERTENSION

Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)

(2008) Aramesh Saremi et al.   ATHEROSCLEROSIS

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control: A randomized, double-blind, placebo-controlled study

(2008) R. A. DeFronzo et al.   DIABETES CARE

Simvastatin suppresses LPS-induced MMP-1 expression in U937 mononuclear cells by inhibiting protein isoprenylation-mediated ERK activation

(2008) Kamala P. Sundararaj et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Relation between interleukin-6 level and subclinical intracranial large-artery atherosclerosis

(2007) Taku Hoshi et al.   ATHEROSCLEROSIS